Judge wrong to find no duty of care in climate change class action, appeal says

Please login to bookmark Close

Imposing a duty of care on the Australian government to protect Torres Strait Islanders from climate change would not involve the Federal Court in matters of political judgment, a failed class action has argued on appeal.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

McCullough Robertson sued over $33M share sale advice

Please login to bookmark Close

A superannuation fund has taken McCullough Robertson to court, arguing that its former solicitors failed to warn that a $33 million share sale agreement with Firecroft Technical Services could be jeopardised if a related Fair Work Commission approval was quashed. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Meriton loses land valuation challenge for Sydney development

Please login to bookmark Close

A court has upheld the $63.8 million valuation of an inner-Sydney high-rise, rejecting Meriton’s argument that it should be reduced to $52 million because of its isolation from public transport.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Builder’s ‘cute’ bid to dodge fire safety fixes at Canberra development rejected

Please login to bookmark Close

Chase Builders can’t avoid completing fire safety rectification works at the Manhattan on the Park apartment complex in Canberra by citing a 10-year limitations period after running down the clock with litigation, a tribunal has said.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

CBEM loses appeal in payment dispute over Dural development

Please login to bookmark Close

A Sydney builder has lost its challenge to a $453,000 judgment for a developer, with an appeals court finding the construction company claimed payment for a greater amount of work than was done on a project in Dural. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Suit accuses Telix of breaching licence agreement for cancer drug Zircaix

Please login to bookmark Close

German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?